Adcetris

Seagen Touts Adcetris Early-Stage Lymphoma Data with 93% Complete Remission
Seagen Touts Adcetris Early-Stage Lymphoma Data with 93% Complete Remission
BioSpace
Seagen
Adcetris
Hodgkin's lymphoma
clinical trials
Flag link:
ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma
ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma
Fierce Pharma
ASCO 2023 - Seagen
Bristol Myers Squibb
Adcetris
Opdivo
antibody-drug conjugate
Hodgkin's lymphoma
Flag link:
Pfizer to buy Seagen in $43B cancer drug deal
Pfizer to buy Seagen in $43B cancer drug deal
BioPharma Dive
Pfizer
Seagen
M&A
lymphoma
Adcetris
Flag link:
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
BioSpace
Seagen
earnings
Merck
M&A
Adcetris
Flag link:
Seagen rolls out data for Adcetris combination to treat Hodgkin lymphoma
Seagen rolls out data for Adcetris combination to treat Hodgkin lymphoma
Endpoints
Seagen
Adcetris
ASH 2022
Hodgkin's lymphoma
Flag link:
Seagen's highest selling drug snags a label expansion for pediatric cancer patients
Seagen's highest selling drug snags a label expansion for pediatric cancer patients
Endpoints
Seagen
Takeda
Adcetris
Hodgkin's lymphoma
FDA
pediatric
Flag link:
Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe
Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe
Yahoo/Zacks.com
Seagen
Adcetris
Padcev
Tukysa
Tivdak
Merck
M&A
Flag link:
ASCO: Seagen, Takeda think Adcetris can become a force as a lymphoma combo drug
ASCO: Seagen, Takeda think Adcetris can become a force as a lymphoma combo drug
Fierce Pharma
ASCO 2022
Seagen
Takeda
Adcetris
lymphoma
Flag link:
Seattle Genetics makes case it can be more than Adcetris
Seattle Genetics makes case it can be more than Adcetris
Biopharma Dive
Seattle Genetics
Adcetris
clinical trials
ESMO
enfortumab vedotin
Astellas
tucatinib
Flag link:
Seattle Genetics' Adcetris sales fall short yet again
Seattle Genetics' Adcetris sales fall short yet again
Biopharma Dive
Seattle Genetics
earnings
Adcetris
Flag link:
Seattle Genetics' Adcetris Progresses Well Amid Competition
Seattle Genetics' Adcetris Progresses Well Amid Competition
Yahoo/Zacks.com
Seattle Genetics
Adcetris
relapsed Hodgkin lymphoma
relapsed systemic anaplastic large cell lymphoma
Flag link:
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
CP Wire
Seattle Genetics
Adcetris
Takeda Pharmaceuticals
Hodgkin's lymphoma
Flag link:
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
Seattle Genetics
Adcetris
Takeda Pharmaceuticals
Hodgkin's lymphoma
Flag link:
Seattle Genetics down on light 2019 Adcetris sales guidance
Seattle Genetics down on light 2019 Adcetris sales guidance
BioCentury
Seattle Genetics
Adcetris
Flag link:
ASH: Seattle Genetics rolls into latest Adcetris launch with double survival win
ASH: Seattle Genetics rolls into latest Adcetris launch with double survival win
Fierce Biotech
Seattle Genetics
Adcetris
ASH 2018
T-cell lymphoma
Flag link:
Adcetris gets speedy label expansion under FDA real-time pilot
Adcetris gets speedy label expansion under FDA real-time pilot
BioCentury
FDA
Adcetris
Seattle Genetics
label expansions
Flag link:
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
CP Wire
Seattle Genetics
Adcetris
T-cell lymphoma
Flag link:
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
Seattle Genetics
Adcetris
T-cell lymphoma
Flag link:
Seattle Genetics sags as Adcetris sales miss target
Seattle Genetics sags as Adcetris sales miss target
BioCentury
Seattle Genetics
earnings
Adcetris
Flag link:
Seattle Genetics' Adcetris Has Potential to Change Treatment for T-Cell Lymphoma
Seattle Genetics' Adcetris Has Potential to Change Treatment for T-Cell Lymphoma
BioSpace
Seattle Genetics
Takeda
Adcetris
peripheral T-cell lymphoma
Flag link:

Pages